Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Plant Advanced Technologies Pat's enterprise value is €8.72 Mil.
Plant Advanced Technologies Pat's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €0.70 Mil. Therefore, Plant Advanced Technologies Pat's EV-to-EBITDA for today is 12.55.
The historical rank and industry rank for Plant Advanced Technologies Pat's EV-to-EBITDA or its related term are showing as below:
XPAR:ALPAT'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -40.61 Med: -20.78 Max: 123.15
Current: 12.55
During the past 13 years, the highest EV-to-EBITDA of Plant Advanced Technologies Pat was 123.15. The lowest was -40.61. And the median was -20.78.
XPAR:ALPAT's EV-to-EBITDA is ranked better than 52.62% of 401
companies
in the Biotechnology industry
Industry Median: 13.8
vs XPAR:ALPAT: 12.55
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Plant Advanced Technologies Pat (XPAR:ALPAT) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Plant Advanced Technologies Pat's PE Ratio (TTM) for today is calculated as:
Plant Advanced Technologies Pat's share price for today is €4.48.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Plant Advanced Technologies Pat's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.507.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Plant Advanced Technologies Pat EV-to-EBITDA Chart
XPAR:ALPAT vs VRTX, REGN, RVMD: EV-to-EBITDA Comparison
For the Biotechnology subindustry, Plant Advanced Technologies Pat's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Plant Advanced Technologies Pat EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Plant Advanced Technologies Pat's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Plant Advanced Technologies Pat's EV-to-EBITDA falls into.
Plant Advanced Technologies Pat's current Enterprise Value is €8.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Plant Advanced Technologies Pat's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €0.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Plant Advanced Technologies Pat (XPAR:ALPAT) has a EV-to-EBITDA of 12.55 as of Aug. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Plant Advanced Technologies Pat. According to the industry distribution chart, Plant Advanced Technologies Pat ranks #190 out of 401 companies in the Biotechnology industry, placing it in the top 47.4%.
Is Plant Advanced Technologies Pat's EV-to-EBITDA too high?
Plant Advanced Technologies Pat's current EV-to-EBITDA is 12.55. The Biotechnology industry median EV-to-EBITDA is 13.80. Plant Advanced Technologies Pat's value of 12.55 is 9.1% below this industry median. Based on the distribution chart, Plant Advanced Technologies Pat ranks #190 out of 401 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Plant Advanced Technologies Pat has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Plant Advanced Technologies Pat's EV-to-EBITDA compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Plant Advanced Technologies Pat ranks #190 out of 401 companies for EV-to-EBITDA. This puts Plant Advanced Technologies Pat in the upper half of its industry. The industry median EV-to-EBITDA is 13.80. Plant Advanced Technologies Pat's value of 12.55 is 9.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.80, based on 401 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Plant Advanced Technologies Pat's current EV-to-EBITDA of 12.55 is 9.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Plant Advanced Technologies Pat. For the Biotechnology industry, the median EV-to-EBITDA is 13.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Plant Advanced Technologies Pat's current EV-to-EBITDA is 12.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plant Advanced Technologies Pat stock overvalued right now?
Based on GuruFocus' analysis, Plant Advanced Technologies Pat (XPAR:ALPAT) is currently considered Possible Value Trap. The stock's GF Value™ is €8.50, compared to a current price of €4.48 — trading 47.3% below its estimated fair value. The current EV-to-EBITDA is 12.55 and 9.1% below the Biotechnology industry median of 13.80. Plant Advanced Technologies Pat's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Plant Advanced Technologies Pat (XPAR:ALPAT), the current EV-to-EBITDA is 12.55 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Plant Advanced Technologies Pat (XPAR:ALPAT) Overvalued in 2026?
Based on GuruFocus' analysis, Plant Advanced Technologies Pat stock appears to be undervalued.
The current stock price of €4.48 is trading 47.3% below its estimated GF Value™ of €8.50.
GuruFocus considers Plant Advanced Technologies Pat to be Possible Value Trap.
Key valuation signals for XPAR:ALPAT:
EV-to-EBITDA: 12.55
GF Value™: €8.50 vs. price of €4.48 (47.3% below fair value)
Industry Position: 9.1% below the Biotechnology median (#190 of 401)
No single metric tells the full story. See the XPAR:ALPAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Plant Advanced Technologies Pat SA is a France-based life sciences company focusing on eco-friendly plant extracts production for pharmaceutical and cosmetic industries. It is also engaged in R & D in the field of plant biotechnology.
46GF Score
Get the complete analysis for XPAR:ALPAT
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALPAT has been successfully added to your 
